idarucizumab (praxbind) Report issue

Biologics mAb Orphan Drug FDA Approved FDA First in Class Accelerated Approval FDA

Back

Chemistry

Mol. Mass

Missing data

ALogP

Missing data

Rule of 5

Missing data

Rule of 3

Missing data
Details

Sources

CHEMBL3544996   ChEMBL
idarucizumab

97RWB5S1U6   NCATS
idarucizumab *

Idarucizumab   Wikipedia

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue